BACKGROUND: Tobacco smoking is a major risk factor for atherosclerotic disease and has been associated with DNA methylation (DNAm) changes in blood cells. However, whether smoking influences DNAm in the diseased vascular wall is unknown but may prove crucial in understanding the pathophysiology of atherosclerosis. In this study, we associated current tobacco smoking to epigenome-wide DNAm in atherosclerotic plaques from patients undergoing carotid endarterectomy.
T obacco smoking is a major risk factor for the development of atherosclerosis and subsequent cardiovascular diseases (CVDs), such as myocardial infarction and stroke. Tobacco smoke contains >5000 toxic chemicals which may jointly contribute to CVD risk. 1 Smoking activates the immune system, facilitates proatherogenic lipid profiles, and induces a prothrombotic state. 2, 3 Moreover, smoking affects the vascular wall, leading to endothelial dysfunction and atherosclerosis. 4 Histological examination of plaques of smokers have shown increased atheroma, decreased fibrous volume, 5 more plaque hemorrhage, 6 and increased inflammation and tissue destruction. 7 All these changes contribute to a plaque composition that is more vulnerable to rupture and more likely to cause cardiovascular events.
Yet, a detailed understanding of the pathophysiological mechanisms underlying these changes remains elusive. Such an understanding may help to identify patients at increased risk because of smoking and may contribute to cessation and preventative treatment strategies. Of equal importance, it may show common pathophysiological pathways of atherosclerosis, shared by multiple risk factors, which may be important for identification of new drug targets.
Large-scale genome-wide association studies (GWAS) have proven instrumental in the investigation of many cardiovascular risk factors and susceptibility to CVD. 8 Smoking has been shown to directly impact CVD risk, 2, 3 and indirectly by modulating the effect of genetic variants on cardiovascular risk factors. [9] [10] [11] [12] [13] Genome-wide genetic studies of smoking have mainly focused on behavioral traits of smoking.
14 Identification of the pathophysiology caused by environmental exposures, such as smoking-induced cardiovascular risk, may require other approaches.
Epigenetics refers to the study of gene expression modifications not caused by changes in the DNA sequence but rather external factors. 15 Epigenetic alterations can be influenced by age, environment, and lifestyle, and aberrant modifications can lead to diseases like cancer and neurodevelopmental disorders. DNA methylation (DNAm) is a key mechanism of epigenetic regulation, whereby a methyl group is added to the cytosine or adenine nucleotides in the DNA molecule; in humans, the most common DNAm is at cytosine in CpG dinucleotides.
DNAm in blood cells has been associated to cardiovascular risk factors, such as body mass index 16 and blood lipid levels. 17 Chemicals in tobacco smoke may change gene expression through DNAm, either adaptive or pathological. Such epigenetic changes have predominantly been shown in circulating cells, in which CpGs were associated to smoking as identified through epigenome-wide association studies (EWAS). [18] [19] [20] [21] [22] [23] [24] [25] Conceivably, the most important insights in vascular pathology may be obtained by scrutinizing the effect of tobacco smoking on DNAm in the vascular lesion itself. To our knowledge, this has not been studied to this date.
In the current study, we performed a 2-stage EWAS of tobacco smoking in carotid atherosclerotic plaques of patients undergoing carotid endarterectomy, reporting 4 loci near AHRR and ITPK1 that are differentially methylated in plaques. Together our findings point to vascular epigenetic mechanisms of smokinginduced CVD.
MATERIAL AND METHODS
This study complies with the Declaration of Helsinki, and all participants provided informed consent. The medical ethical committees of the respective hospitals approved these studies. Detailed Material and Methods are available in the Data Supplement.
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. The raw omics data are available through the European Genome-Phenome Archive. The main scripts used for the quality control and the meta-analysis of the data are available through GitHub.
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RESULTS
We performed a 2-stage EWAS of plaque-derived DNAm with current tobacco smoking in carotid endarterectomy patients from the Athero-Express Biobank Study (AEMS450K1 discovery study and AEMS450K2 replication study; Table 1 ; Figure I in the Data Supplement). In the discovery study, 10 CpGs across 6 genes (Table 2; Figure 1A ; Figure II in the Data Supplement) were associated to tobacco smoking (at P ≤1.13×10 -6 [false discovery rate (FDR) ≤0.05]). To assess the validity of these associations, we performed a second methylation experiment ( Figure 1B ; Figure III in the Data Supplement) and replicated 4 CpGs (at P=0.05/10=0.005; Table 3 ). We then performed a fixed-effects meta-analysis of these datasets and found 4 CpGs that were associated to current tobacco smoking in plaques at FDR <0.05 mapping to 6 different genes (Table 4; Figure 1C ; Figure IV in the Data Supplement). All of these 4 CpGs showed reduced DNAm in current smokers as compared with former or never smokers (Figure 2) . A sensitivity analysis on the number of estimated pack-years of smoking showed 2 of these 4 nominally associated (cg05575921 near AHRR and cg05284742 near ITPK1; Table I in the Data Supplement).
To study the possible effect of smoking-induced methylation changes on the carotid atherosclerotic plaque in more detail, we investigated histological features of the plaques. Considering data from the whole Athero-Express Biobank (N=2319), current tobacco smoking behavior was associated with more calcifica-tion (odds ratio, 1.42; 95% CI, 1.13-1.81; P=0.0034) and collagen deposition (odds ratio, 1.47; 95% CI, 1.09-1.97; P=0.0112) in atherosclerotic plaques (Table   II in the Data Supplement). However, none of the 4 CpGs associated to smoking was associated to specific plaques characteristics (Table III in the Data Supplement). Patient characteristics at time of inclusion in both datasets, stratified by smoking status. Patients without data on current smoking were excluded. Significance shown as P values without FDR adjustment. Ocular denotes retinal infarction and amaurosis fugax. BMI indicates body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate by MDRD-formula; FDR, false discovery rate; LLDs, use of lipid-lowering drugs; MDRD, Modification of Diet in Renal Disease Study equation; SBP, systolic blood pressure; and TIA, transient ischemic attack.
*Symptoms at presentation before carotid endarterectomy. 1.24×10 -7 Chr:BP denotes chromosome base-pair position of the methylation probes (CpG); strand, strand position of the methylation site; gene, the gene mapped to the CpG; beta, effect size; P value, P value of association before bacon correction; P corr , P value of association after bacon correction; se, standard error.
*Replicated CpGs.
DNAm in Blood
In addition to the analysis in plaque specimens, we performed an EWAS between blood-derived DNAm and current tobacco smoking in 89 blood samples ( Figure 3 ; Figure V in the Data Supplement; Table IV in the Data Supplement). We identified 17 significant (FDR ≤0.05) CpGs in blood, mapping to 8 genes, 1 long-noncoding RNA, and 1 microRNA (Table 5) , all of which showed lower DNAm in current smokers compared with former or never smokers. Of these 17 CpGs, 8 have previously been associated with smoking in blood and other tissues (Table 5) , [18] [19] [20] [21] 23, [27] [28] [29] [30] confirming the relevance of previously reported loci in patients with severe atherosclerotic disease.
Correlations to RNA
To investigate possible effects of the tissue-specific CpGs on local gene expression, we performed a pilot RNA-sequencing experiment using plaque-derived whole-tissue RNA (n=21). None of the genes mapped to the 4 plaque-derived CpGs were significantly associated to current smoking status (Table V in the Data  Supplement) . However, when comparing the direction of effects of all nominal significant CpGs with the gene expression, the correlation was significant for CpGs mapped to 1500 or 200 bp from the transcription start site and for CpGs mapped to the first exon ( Figure 6 in the Data Supplement). (A) the discovery (AEMS450K1), (B) the replication (AEMS450K2) cohorts, and (C) the meta-analysis (n=664). Each point represents an individual CpG, with the x axis shows the genomic location of each CpG and the y axis shows the observed -log 10 (P value) of the association with current tobacco smoking after meta-analysis. Loci with CpGs that were epigenome-wide significant after replication at are shown in gray.
Genetic Variation
The susceptibility of CpGs to undergo epigenetic modifications because of environmental factors may be modified by genetic variation. Therefore, we associated DNAm at the smoking-associated CpGs in plaque with nearby common DNA sequence variation. We identified a common variant, rs4956991 (c.*1078A>G, effect allele frequency=0.65) in the 3' untranslated region of PLEKHGB4, that associated to methylation at the cg02385153 in AHRR (β=−0.020±0.003 SE; P=1.52×10 -9 which equals FDR=6.51×10 -8 ; Figure 4) . 30 This suggests that DNAm at the smoking-related CpG cg02385153 may also be affected by genetic variation 221 251 bp upstream of the AHRR gene.
To investigate if this methylation quantitative trait locus also indicates coregulatory gene-gene interaction, we determined the relationships between common genetic variation, CpGs, and the expression of the involved genes (PLEKHG4B and AHRR). Exploring data from Genotype-Tissue Expression Portal (https://www. gtexportal.org), 32 we found rs4956911 also to be an expression quantitative trait loci of PLEKHG4B in multiple tissues but not of AHRR (β=−0.32; P=2.1×10 -11 ; Figure VII in the Data Supplement). In addition, while exploring data from gnomAD, 33 we found 1 nonsynonymous variant, rs4956987, that may alter the function of the PLEKHG4B (pleckstrin homology domain-containing family G member 4B) protein (P.Arg1076Gln, β=−0.012±0.003 SE; P=2.40×10 -4 which equals FDR=3.64×10 -3 ). Finally, we show positive associations between expression of the genes AHRR and PLEKHG4B, in multiple CVD related tissues in the STAGE cohort (Study of Twin Adults: Genes and Environment) ( Table  VI in 
DISCUSSION
We performed a 2-stage epigenome-wide association study on smoking in 664 carotid atherosclerotic plaque samples. This study shows that smoking is strongly associated with differential DNAm in carotid atherosclerotic plaques. As far as we know, this is the first study reporting 4 CpGs differentially methylated in DNA derived from Chr:BP denotes chromosome base-pair position of the methylation probes (CpG); Gene, the gene mapped to the CpG; beta, effect size; P value, P value of association before bacon correction; and P corr , P value of association after bacon correction; se, standard error. *Replicated CpGs. Chr:BP denotes chromosome base-pair position of the methylation probes (CpG); gene, the gene mapped to the CpG; beta: effect size; P value, P value of association before bacon correction; P corr , P value of association after bacon correction; and FDR, the FDR adjusted Q value of association. CPG indicates cytosine-guanine nucleotide pairs separated by a phospho-group; and FDR, false discovery rate.
plaques because of tobacco smoking (Table 4 ). In addition, we could replicate 8 CpG loci known to associate with smoking in circulating cells (Table 5) . [18] [19] [20] [21] 23, [27] [28] [29] [30] 34 This study provides supporting evidence for an effect of smoking on epigenetic regulation in atherosclerotic vascular tissue. This is strengthened by the partial similarity observed in DNAm patterns between blood and plaque. For example, multiple associations with smoking were observed at CpG loci near AHRR, a regulator of the AhR (aryl hydrocarbon receptor) transcription factor and its pathway. Differential DNAm at this locus has been associated with smoking on numerous occasions and various tissues, including pulmonary macrophages and neonatal cord-blood. [18] [19] [20] [21] [23] [24] [25] [26] [27] [28] [29] 33 Furthermore, this relationship has also been shown in a mouse model in which lower DNAm at the AHRR gene was associated with higher AHRR expression. 21 The AhR transcription factor is a xenobiotic receptor, sensitive to some endogenous ligands, as well as many exogenous toxins. These toxins include polycyclic aromatic hydrocarbons and dioxins both of which are important constituents of tobacco smoke 35 and lead to upregulation of enzymes involved in the detoxifying metabolism of these substances.
The other smoking-associated CpG locus is located near ITPK1 (a gene encoding for inositol-tetrakisphosphate 1-kinase) and earlier studies had associated the same locus to differential methylation in circulating blood cells. 18, 36, 37 The ITPK1 enzyme functions as a key regulator of the rate-limiting step in the inositol metabolic pathway pivotal in the formation of phosphorylated forms of inositol. 38 Inositol has been implicated in neural tube defects 39 and has a role in transcriptional regulation. 40 Although differential methylation at ITPK1 has been implicated with smoking before, the exact biological implications and the role of ITPK1 or inositol in response to smoking remains unknown.
Furthermore, smoking was associated with several CpGs in our discovery dataset that were identified in literature before. For instance, we identified cg16650073 near NTHL1 encoding for endonuclease III-like protein 1, an enzyme that is involved in nucleotide base-excision repair of DNA. Interestingly, NTHL1 expression was shown to be Each point represents an individual CpG, with the x axis shows the genomic location of each CpG and the y axes shows the observed -log 10 (P value) of the association with current tobacco smoking. CpGs that were epigenome-wide significant after false discovery rate (FDR) correction at FDR ≤0.05 are shown in gray.
reduced in lung tumor biopsies in humans, 41 and smoke exposure was shown to reduce NTHL1 (endonuclease III-like protein 1) protein expression in mice lung fibroblasts. 42 Our results suggest that smoke exposure may inhibit DNA-repair in vascular tissue through downregulation of NTHL1 expression. This notion is further supported by a study showing that reactive oxygen species can induce DNA oxidation, leading to aberrant regulation of NTHL1. 43 Indeed, it is known that both tobacco smoking and reactive oxygen species cause vascular endothelial dysfunction leading to endothelial activation and vascular smooth muscle cell proliferation and ultimately atherosclerosis. Our data adds to this by supporting a role for epigenetic regulation in atherosclerotic lesions through demethylation of NTHL1, AHRR, and other cellular maintenance genes. These data imply that epigenetic changes may adversely affect vascular tissue and thereby affect atherosclerotic lesion development and progression.
In addition, it is remarkable that our results in bloodderived DNAm also indicate a significant association at cg03636183 in the F2RL3-gene (coagulation factor II receptor-like 3). 20, 44 Indeed, hypomethylation at this locus in blood cells has been reported to associate strongly with current and long-time tobacco smoke exposure. 45 This protease-activated receptor is involved in cardiovascular pathophysiological processes, including thrombininduced platelet-aggregation, 46 as well as inflammation. 47 Also, methylation at F2RL3 in blood cells is shown to be a predictor for lung cancer 48 and mortality. 49 Genetic variation may affect methylation status of specific genes. Using methylation quantitative trait locus analysis, we found strong associations between lesion CpGs and nearby variants, showing that some of the smokingassociated CpG methylations may be affected by genetic variation. Therefore, these variants are of particular interest because they may reveal hereditary susceptibility to toxicity in the vascular wall. Not much is known about the biological functions of the PLEKHG4B genes, and further research should focus on their relationship with smoking.
Our observations in pilot data suggest that smoking affects the atherosclerotic vascular lesion at the epigenetic level, which may affect local gene expression levels ( Figure VI in the Data Supplement). Although the concept of transcriptional regulation by DNAm has been abundantly shown, 50 the effect of a particular CpG on local gene expression is complex. Elucidation of the effects of CpGs on gene expression within the atherosclerotic vascular wall tissue in larger samples may offer important insights into the biological mechanisms by which tobacco smoking confers an increased cardiovascular risk.
Most epigenetic smoking studies to date have focused on blood-derived DNAm. To gain better insight in the tissue specificity of the methylation results obtained in atherosclerotic plaques and to 1.36×10 -6 0.035
Chr:BP denotes chromosome base-pair position of the methylation probes (CpG); gene, the gene mapped to the CpG; beta, effect size; P value, P value of association before bacon correction; P corr , P value of association after bacon correction; and FDR, the FDR adjusted Q value of association. CPG indicates cytosine-guanine nucleotide pairs separated by a phospho-group; DNAm, DNA methylation; and FDR, false discovery rate.
*CpGs that were also significant in the final meta-analysis of plaque-derived DNAm.
verify consistency with pre-existing studies, we also performed an EWAS in blood samples from the same patients. Furthermore, we carefully scrutinized literature investigating blood or other tissues. The combined results of the literature search and our experimental data suggest vasculature-specific methylation differences induced by tobacco smoking. This emphasizes the importance of investigating DNAm in the vascular lesion itself, as well as the need for further validation in external studies.
Limitations of the Current Study
Our analyses are based on patients' current smoking behavior, which will not reflect time-dependent effects of smoking on plaque methylation, 51 as patients may be light or heavy smokers in the past. Thus, our results may apply specifically to active or recent (<1 year) smokers. Although we show strong associations and correct for inflation and bias using Bayesian modeling, it is impossible to exclude residual confounding or misclassification bias as a consequence of self-reported smoking behavior. This is complicated by the differences in DNAm between cell types in the sample; indeed, the limited replication (4 out of 10 CpGs are significant) are indicative of cellular heterogeneity. Future studies focused on single-cell methylation, and tissue-specific spatial methylation can aid in determining the relevant cell types in tobacco smoking-induced epigenetic regulation in vascular lesions.
Gene regulation and expression are thought to act on cellular and tissue function, and thus ultimately on intermediate phenotypes. Yet, we did not find an association between the smoking-associated DNAm and plaque characteristics. This may be a reflection of low power because of the heterogeneity of the tissue in which we measured methylation. In addition, it is uncertain what the correlation is between methylation and protein levels that ultimately affect cellular function and intermediate phenotypes.
Furthermore, it should be noted that the AtheroExpress Biobank is a cohort of patients with advanced atherosclerotic disease. Therefore, it merits careful consideration to draw inferences on earlier stages of atherosclerotic disease. This selected group of atherosclerotic patients with advanced stages of disease may also explain the lack of association with plaque characteristics.
Finally, our replication dataset was of limited sample size, reducing power in the meta-analysis. Future studies should aim to include more samples for discovery and replication.
In summary, we performed a 2-stage epigenome-wide association study of current smoking in 664 atherosclerotic plaque samples and 89 peripheral blood samples derived from 668 carotid endarterectomy patients. We show that tobacco smoking is associated with DNAm at 
